Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 10, Issue 6, 1996, Pages 1005-1008

  Harris, A W ^a,c   Pryce, D I ^a   Gabe, S M ^a   Karim, Q N ^a   Walker, M M ^a   Langworthy, H ^b   Baron, J H ^a   Misiewicz, J J ^a  

^a Parkside Helicobacter Study Group   (United Kingdom)

^b Lederle Laboratories   (United Kingdom)

^c EALING HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BREATH ANALYSIS; DRUG EFFICACY; DRUG RESISTANCE; DRUG TOLERANCE; FEMALE; GASTRITIS; GASTRODUODENAL ULCER; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIDE EFFECT;

EID: 0029849823     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1996.100272000.x     Document Type: Article

References (10)

1. Bazzoli F, Zagari RM, Fossi S, Pozzato P, Roda A, Roda E. Efficacy and tolerability of a short term, low dose triple therapy for eradication of H. pylori. Gastroenterology 1993; 104(4): A40(Abstract).
2. Lind T, Velduyzen van Zanten SJO, Unge P. et al. The MACH 1 study: optimal one-week treatment for H. pylori defined? Gut 1995; 37: A4(Abstract).
3. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, Langworthy H. One week low-dose triple therapy for eradication of H. pylori: a large multicentre randomised trial. Gut 1996; 38: A1(Abstract).
4. Banatvala N, Davies GR, Abdi Y, et al. High prevalence of Helicobacter pylori metronidazole resistance in migrants to east London: relation with previous nitroimidazole exposure and gastroduodenal disease. Gut 1994; 35: 1562-6.
5. Ching CK, Leung KP, Yung RWH, et al. Prevalence of metronidazole resistant Helicobacter pylori strains among Chinese peptic ulcer disease patients and normal controls in Hong Kong. Gut 1996; 38: 675-8.
6. Bazzoli F, Zagari RM, Fossi S, et al. Short-term, low-dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994; 6: 773-7.
7. Moayyedi P, Sahay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7: 835-40.
8. Logan RPH, Gummett PA, Misiewicz JJ, Karim QM, Walker MM, Baron JH. One week eradication regime for Helicobacter pylori. Lancet 1991; 338: 1249-52.
9. 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3: 915-21.
10. Malferteiner P. Compliance, adverse events and antibiotic resistance in Helicobacter pylori treatment. Scand J Gastroenterol 1993; 196: 34-7.